General


Peptide: NRC-16
Microorganism:Pseudomonas aeruginosa
Administration:
Stage: Formation (3-24h)
Notes:

Experimental procedure


Method AMP Effect(Biofilm reduction) Concentration Notes
Crystal violet assay > 90% 8 uM clinical isolate 1162
Crystal violet assay > 90% 8 uM clinical isolate 3547
Crystal violet assay > 90% 16 uM clinical isolate 4007
Crystal violet assay > 90% 8 uM clinical isolate 3399
Crystal violet assay > 90% 16 uM clinical isolate 1034

Reference



M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.

Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or gpmaccari@gmail.com